There are two ways out, transplantation can be a cure, but it is risky and has many conditions. Gleevec class of drugs can control the condition for a long time and is considered close to a cure, but it cannot be stopped. Gleevec is more expensive, but you can join the GIPAP assistance program of China Charity Federation, which costs about 80,000 per year. The patent expires in 2014, and there may be domestic drugs instead. Duan Minghui, Department of Hematology, Peking Union Medical College Hospital Older methods such as interferon and hydroxyurea can only control the disease in the short term, but cannot avoid acute changes and eventually inevitably do not cure.